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Objectives: The aim of the present study was to retrospectively evaluate the prevalence of concurrent coronary
artery disease in patients who underwent surgery due to severe valvular heart disease. The study also investigated
the association of coronary artery disease with the type of valvular heart disease.
Materials and methods: A total of 241 patients (123 females [51%]), who had underwent single valvular heart
surgery, were included in the study. The patients who underwent valve replacement surgery were divided into four
groups: patients with severe mitral stenosis (MS), patients with severe mitral regurgitation (MR), patients with severe
aortic regurgitation (AR), and patients with severe aortic stenosis (AS). Age, DM, HT, history of smoking, and LDL
values were recorded as the risk factors for CAD.
Results: Coronary artery disease was detected in 26.4% of patients with mitral stenosis and 57.7% of patients with
aortic stenosis. Of the patients with mitral insufficiency, 41.9% had CAD, and 44.4% of the patients with aortic
insufficiency had CAD.
Conclusion: The comparison of MS and AS groups revealed significantly higher prevalence of CAD in the AS
group. There was no statistically significant difference between the MR and AR groups in terms of the prevalence of
CAD. The comparison of MS and MR groups revealed significantly higher prevalence of CAD in the MR group.
Furthermore, the comparison of these groups in terms of the extensiveness of the coronary artery disease revealed
significantly higher Gensini score in the MR group.
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Currently, rheumatic factors in the etiology of valvular
heart diseases have been mostly replaced by degenerative
factors, the prevalence of which increase with increasing
age [1]. In parallel to the change in the epidemiology of
valvular heart disease, coronary artery disease (CAD) have
become more commonly found in association with valvu-
lar heart disease particularly in the developed western
countries [1]. The prevalence of degenerative aortic valve
disease increases with age and it is the leading valvular
condition accompanying CAD. Ischemic mitral valve in-
sufficiency has become the focus of recent studies with re-
gard to its diagnosis and treatment approaches [1].* Correspondence: zeynepyapan@hotmail.com
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unless otherwise stated.The aim of the present study was to retrospectively
evaluate the prevalence of concurrent coronary artery
disease in patients who underwent surgery due to se-
vere valvular heart disease and to investigate the associ-
ation of coronary artery disease with the type of
valvular heart disease.Methods
Patient group
The medical records of 241 patients, who underwent
valvular heart surgery in the Department of Cardiovascular
Surgery in three different centers (Celal Bayar University
Hafsa Sultan Hospital, Tepecik Training and Research
Hospital, and Katip Celebi University Ataturk Training and
Research Hospital) between 2004 and 2012, were retro-
spectively reviewed. The results of coronary angiog-
raphy performed before the operation and biochemicalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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four groups: patients with severe mitral stenosis (MS), pa-
tients with severe mitral regurgitation (MR), patients with
severe aortic regurgitation (AR), and patients with severe
aortic stenosis (AS). In addition, cardiovascular risk fac-
tors of the patients (age, gender, hypertension, smoking,
diabetes mellitus) were recorded. The study was approved
by the ethics committee of the Celal Bayar University
Faculty of Medicine.
The patients who underwent multiple valvular heart
surgery, patients aged below 18 years, patients who did
not undergo coronary angiography, patients with mitral
regurgitation whose transthoracic echocardiographic
findings suggestive of ischemic etiology (ischemic left
ventricular dysfunction, regional dysfunction of the LV
myocardium, eccentric MY vs.), patients with mild and/
or moderate valvular heart disease, re-operated cases
due to prosthesis valve dysfunction, those with a previ-
ous history of valvular repair and balloon valvuloplasty
were excluded from the study.
Coronary angiography
The coronary angiography results were considered nor-
mal in the absence of plaques, irregular contour, ectasia,
and slow flow in all epicardial coronary arteries (includ-
ing lateral branches); however, coronary artery disease
was defined as the presence of at least one of the above-
stated conditions. The Gensini scoring system was used
to evaluate the severity of CAD [2]. According to this
scoring system, angiographic severity of the lesion was
rated as follows: 1 point = 0-25%, 2 points = 25-50%, 4
points = 50-75%, 8 points = 75-90%, 16 points = 90-99%,
and 32 points = 100% completely occluded vessel. The
severity score was multiplied by the segment location
multiplying factor (left main coronary artery lesion = 5
points, proximal left descending branch and left circum-
flex artery lesion = 2.5 points, middle left descending
artery lesion = 1.5 points, first diagonal branch and the
branches of obtus marginalis, and right coronary artery
lesion = 1 point, and second diagonal and left circumflex
artery posterolateral branch lesion = 0.5 points), and the
results were summed to yield the Gensini score for each
patient group.
Statistical analysis
SPSS for Windows IBM SPSS Statistics 20 software pack-
age was used in the statistical analyses. The continuous
variables were expressed as mean ± standard deviation,
and non-continuous variables were expressed as propor-
tion. The Student’s t-test was used in the comparison of
quantitative data with normal distribution, and chi-square
test was used in the comparison of qualitative data. One-
way ANOVA test was used in the comparison of multiple
groups. The Kolmogorov-Smirnov test was used to testwhether the variables were normally distributed. The
Pearson’s correlation coefficient was used in the correl-
ation analysis. P values <0.05 were considered statisti-
cally significant.
Results
A total of 241 patients (123 females [51%]), who under-
went valvular heart disease, were included in the study.
The study included 72 patients (29.9%) who underwent
MVR due to severe mitral stenosis, 93 patients (38.6%)
who underwent MVR due to severe mitral regurgitation,
40 patients (16.6%) who underwent AVR due to severe
aortic stenosis, and 36 patients (14.9%) who underwent
AVR due to severe aortic regurgitation. The demographic
features of the patients are presented in Table 1. The Gen-
sini scores in patients with DM and HT were found to be
higher compared to patients without DM or HT (p = 0.012
and 0.026, respectively).
The coronary angiography results of the patients are
presented in Table 2. There was significant difference
between the groups in terms of the presence of CAD
(p = 0.01). The prevalence of CAD was higher in patients
with AS when compared to patients with MS (p = 0.002).
The prevalence of CAD was higher in patients with MR
when compared to patients with MS (p = 0.02). Although
the difference between the groups in terms of the Gensini
score did not reach statistical significance, the patients
with MR had significantly higher Gensini score compared
to patients with MS (2.97 ± 8.75 versus 11.02 ± 25.26,
p = 0.005). CABG surgery was performed in addition to
valvular heart surgery in 25% of the patients in the AS
group, 12.9% of the patients in MR group, 8.3% of the pa-
tients in MS group, and 16.7% of the patients in AR group.
There was significant difference between the groups in
terms of left ventricular ejection fraction (p = 0.03). In
Pearson’s correlation analysis, LDL value was found to
be correlated with the Gensini score (R = 0.171, p = 0.008).
There was no significant correlation between the Gensini
score and fasting blood glucose level (p = 0.85). There was
inverse correlation between LVEF and the Gensini score
(p < 0,001 R = −0,373). There was no significant correl-
ation between pulmonary hypertension and the Hensini
score (p = 0.20).
Discussion
The previous studies have reported various prevalence
rates for coronary artery disease in patients with valvular
heart disease [1,3-12]. However, there is no study in the
literature that compared the patients with valvular disease
as separate groups. In the present study, the patients who
underwent valve replacement surgery due to severe
valvular heart disease were evaluated in four different
groups: patients with severe mitral stenosis, patients
with severe mitral regurgitation, patients with severe
Table 1 The demographic features of the study patients
MS (MVR) (n = 72) MR (MVR) (n = 93) AS (AVR) (n = 40) AR (AVR) (n = 36) P value
Age 52.23 ± 10.05 56.62 ± 12.07 63.52 ± 13.36 55.19 ± 14.21 0.000
HT (%) 5 (15.6) 15 (46.9) 7 (21.9) 5 (15.6) 0.008
DM (%) 20 (18.7) 47 (43.9) 22 (20.6) 18 (16.8) 0.284
History of Smoking (%) 22 (27.5) 28 (35) 15 (18.8) 15 (18.8) 0.547
TG (mg/dL) 116.18 ± 65.85 147.84 ± 95.40 143.32 ± 95.17 147.38 ± 75.42 0.087
LDL (mg/dL) 114.25 ± 32.06 112.37 ± 37.05 122.87 ± 39.35 114.88 ± 31.36 0.468
HT, hypertension; DM, diabetes mellitus; TG, triglyceride; LDL, low-density lipoproteins; MS, mitral stenosis; MR, mitral regurgitation; MVR, mitral valve replacement;
AS, aortic stenosis; AR, aortic regurgitation; AVR, aortic valve replacement.
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stenosis. There was significant difference in terms of the
prevalence of CAD when the groups were compared
with each other and as a whole. In the study by Bozbas
et al., out of 346 patients who underwent surgery due to
rheumatic heart disease, 218 (63%) underwent coronary
angiography, and 18.8% of the patients were found to
have CAD [1]. In the study by Chun et al., 82 patients with
MS underwent CAG, and 21 patients (26%) were found to
have CAD [7]. Similar studies on patients with aortic sten-
osis reported a 56% prevalence rate for CAD [8,9]. In the
study by Shaikh et al. that evaluated 144 patients who
underwent replacement of mitral valve, aortic valve or
both, there was evidence for severe CAD in 32.9% of the
patients who underwent MVR, 31.9% of the patients who
underwent AVR, and 25% of the patients who underwent
the replacement of both valves [10]. In the present study,
26.4% of patients with MS, 42% of the patients with MR,
57.5% of the patients with AS, and 44.4% of the patients
with AR had CAD, a finding similar to that reported in
the literature.
The atherosclerosis plays a role in the etiology of aor-
tic stenosis as it already does in the etiology of CAD.
Age-related calcification of the aortic valve is the most
common cause of AS in the adult population [11]. The
presence of calcific valve disease is associated with 50%
increased risk of cardiovascular death and myocardial
infarction even in the absence of valvular obstruction
[12-14]. Valvular calcification is mediated by proliferative
and inflammatory processes including lipid deposition,Table 2 The results of CAG in the study patients
MS (MVR) (n=72) MR (MVR) (n=93)
Presence of CAD* 19 (26.4%) 39 (42%)
Gensini score** 2.97±8.75 11.02±25.26
CABG (%) 6 (8.3%) 12 (12.9%)
LVEF (%) 54.93±7.45 50.29±12.05
CAG, Coronary artery angiography; MS, mitral stenosis; MR, mitral regurgitation; MV
aortic valve replacement. CAD, Coronary artery disease; CABG, Coronary artery bypa
*The prevalence of CAD was significantly higher in AS group compared to MS grou
compared to MS group (p=0.02).
**The Gensini score was significantly higher in MR group compared to MS group (pup-regulation of angiotensin converting enzyme activity,
and infiltration of macrophages and T-lymphocytes
[11,12,15,16]. The risk factors for the development of
calcific AS are similar to those involved in the development
of vascular atherosclerosis. These risk factors include in-
creased LDL-cholesterol and lipoprotein a, diabetes melli-
tus, smoking history, and hypertension. The retrospective
studies have demonstrated slower progression rates in cal-
cific AS with the administration of statin therapy [17-19],
and this effect was further confirmed in an animal
model [20]. Therefore, there is a growing consensus that
degenerative calcific AS shares common pathophysiological
features and metabolic pathways with atherosclerosis that
can be targeted to prevent or delay the progression of
disease [13,16,21,22].
Furthermore, CAD plays a role in the etiology of MR.
The disorders of the left ventricular papillary muscle are
common causes of MR due to the fact that these mus-
cles are supplied by the terminal portion of the coronary
vascular bed and particularly sensitive to ischemia. The
impairment in the coronary perfusion may result in pap-
illary muscle dysfunction. A transient ischemia results in
a temporary papillary muscle dysfunction and temporary
MR [23]. A sustained and severe ischemia in the papil-
lary muscle results in papillary muscle dysfunction and
scarring, and the development of chronic MR. The ische-
mic conditions more commonly affect the posterior papil-
lary muscle compared to anterolateral papillary muscle.
The ischemia in papillary muscle is mostly caused by
coronary atherosclerosis. MR often develops in patientsAS (AVR) (n=40) AR (AVR) (n=36) P value
23 (57.5%) 16 (44.4%) 0.01
11.20±28.26 7.55±16.98 0.077
10 (25%) 6 (16.7%) 0.102
53.12±10.30 50.25±13.07 0.03
R, mitral valve replacement; AS, aortic stenosis; AR, aortic regurgitation; AVR,
ss graft; LVEF, Left ventricular ejection fraction.
p (p=0.002). The prevalence of CAD was significantly higher in MR group
=0.005).
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common cause of regurgitation is regional dysfunction in
the left ventricular myocardium at the base of the papillary
muscle that results in incomplete leaflet coaptation. Ische-
mic left ventricular dysfunction and dilated cardiomyop-
athy are important etiological factors in the development
of MR. The dilation of the left ventricle due to any reason
including ischemia changes the spatial relation between
the papillary muscles and chorda tendinea and therefore
contributes to the development of MR [24-27]. A certain
extent of MR is found in 30% of patients being considered
for coronary artery bypass grafting. In these patients, MR
is secondary to ischemic damage of the papillary muscles
and/or enlargement of the mitral valve. MR develops in
20% of the patients following acute myocardial infarction,
and the prognosis is poor in these patients even in the
presence of mild MR [28,29]. From this point of view, the
present study investigated whether the prevalence of CAD
significantly differed depending on the type of valvular
heart disease. Different than the other studies, the present
study compared all four groups in terms of the presence
of CAD and found significant difference between the four
groups. The prevalence of CAD was significantly higher in
patients with AS when compared to patients with MS.
The high prevalence of CAD in patients with AS reflects
the role played by the atherosclerotic process in the eti-
ology of AS. The prevalence of CAD was significantly
higher in patients with MR when compared to patients
with MS. The patients with MR are expected to have
higher prevalence of CAD compared to patients with
MS due to the fact that CAD plays a major in the eti-
ology of MR.
In the study by Lacy et al., the patients were evaluated
for the presence of concurrent CAD (50% or greater
occlusion in at least one major coronary artery), they
found that 31.3% of the patients with MS had CAD and
19% had occlusive CAD, and 36.3% of the patients with
MR had CAD and 18% had occlusive CAD, and 58.9% of
the patients with AS had CAD and 21% had occlusive
CAD, and 36.6% of the patients with AR had CAD and
30% had occlusive CAD [30].
Sonmez et al. evaluated 760 patients who underwent
valvular heart surgery, and they found occlusive CAD in
15.8% of the patients (p < 0.001), and the highest preva-
lence rate was noted in patients with AS (p < 0.05), a find-
ing similar to that reported in the present study. The risk
factor most commonly associated with CAD was the
family history followed by DM, hyperlipidemia, HT, and
smoking [31]. In the present study, DM had the most sig-
nificant association with CAD.
The prevalence rate reported in the present study for
CAD is in general similar to that reported in the literature.
Although the patients with AR had higher prevalence of
CAD compared to patients with MR, the Gensini scorewas found to be higher in patients with MR when
compared to those with AR. The difference between the
groups, however, did not reach statistical significance. The
findings of the present study in terms risk factors for CAD
are similar to those reported in the literature. The present
study differ from the literature in that the patients in the
present study were grouped based on the presence of se-
vere valvular pathologies.
Conclusion
In the present study there was significant difference
between the groups in terms of the presence of CAD
(p = 0.01). The prevalence of CAD was higher in patients
with AS when compared to patients with MS (p = 0.002).
The high prevalence of CAD in patients with AS reflects
the role played by the atherosclerotic process in the eti-
ology of AS. The prevalence of CAD was significantly
higher in patients with MR when compared to patients
with MS. The patients with MR are expected to have
higher prevalence of CAD compared to patients with
MS due to the fact that CAD plays a major in the eti-
ology of MR. The findings of the present study in terms
risk factors for CAD are similar to those reported in the
literature.
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